Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Small molecules affecting transcription in Friedreich ataxia.

Pharmacology & therapeutics - 1 Nov 2007

Gottesfeld Joel M

Abstract excerpt

This review concerns the development of small molecule therapeutics for the inherited neurodegenerative disease Friedreich ataxia (FRDA). FRDA is caused by transcriptional repression of the nuclear FXN gene, encoding the essential mitochondrial protein frataxin and accompanying loss of frataxin p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Models, Animal
Share to Enzyme Inhibitors
Share to Frataxin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Friedreich Ataxia

Share to Gene Expression Regulation

Share to Histone Deacetylase Inhibitors

Share to Iron-Binding Proteins

Share to Transcription, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 17826840
DOI: 10.1016/j.pharmthera.2007.06.014
PMCID: PMC2080619

Genes

FXN
GAA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17826840-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Small molecules affecting transcription in Friedreich ataxia.PMID 17826840Read ↗

Advances in Gene and Cellular Therapy in Friedreich Ataxia.Semantic proximity Read ↗

From Genetic Mutation to Therapy in Friedreich Ataxia: Molecular Mechanisms, Therapeutic Advances, and Translational ChallengesSemantic proximity Read ↗

Translating HDAC inhibitors in Friedreich’s ataxiaSemantic proximity Read ↗

Pathophysiogical and therapeutic progress in Friedreich ataxia.Semantic proximity Read ↗

Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.Semantic proximity Read ↗

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxiaSemantic proximity Read ↗

Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.Semantic proximity Read ↗

Friedreich's ataxia: new insightsSemantic proximity Read ↗

Unanswered Questions in Friedreich AtaxiaSemantic proximity Read ↗

Friedreich's ataxia: treatment within reach.Semantic proximity Read ↗

Transcriptional profiling of isogenic Friedreich ataxia induced pluripotent stem cell-derived neuronsSemantic proximity Read ↗

A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.